QUEST LABORATORIES
|
|
| BOM :      NSE : QUESTLAB     | |
| LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 12,2026 |
|
Price(EOD): ₹ 101.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 165.72 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| QUEST LABORATORIES | -0.1% | -10.3% | 16.3% |
| SUN PHARMACEUTICAL INDUSTRIES | 1% | -0.9% | 6.8% |
| DIVIS LABORATORIES | 1.8% | -2.3% | 1.5% |
| TORRENT PHARMACEUTICALS | 3.7% | 6.5% | 44.9% |
| CIPLA | 0% | 4.7% | -8% |
| DR REDDYS LABORATORIES | -0.2% | 0.7% | -3.4% |
| MANKIND PHARMA | 0.9% | -1.2% | 0.8% |
| LUPIN | 1.8% | 3.5% | 13.8% |
| ZYDUS LIFESCIENCES | 1.6% | 17.6% | 15.2% |
FUNDAMENTAL ANALYSIS OF QUEST LABORATORIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF QUEST LABORATORIES
 | Ratio | Standalone | |
|---|---|---|
|
P/E P/B P/S |
11.03
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 15.02 Cr
[Latest Qtr - Mar2026 - Standalone Results ] 2.02
P/B Calculated based on Book Value of Rs 81.80 Cr
[Latest Year - Mar2025 - Standalone Results ] 1.48
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2026 - Standalone Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
NA NA (-ve EV) 1% |
SHARE PRICE MOMENTUM OF QUEST LABORATORIES
QUEST LABORATORIES vs SENSEX
DEBT OF QUEST LABORATORIES
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.37 0.18 0.27 0.27 |
- - - - |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF QUEST LABORATORIES
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF QUEST LABORATORIES
| Standalone | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
5.86% -40.18% -63.85% -28.76% |
-30.24% 260.73% -32.92% 48.04% |
| QtrlyTrend |
-2 | |
| Latest Qtr: Mar2026 | ||
| Quarterly Result Analysis → | ||
QUEST LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about QUEST LABORATORIES
Is QUEST LABORATORIES good for long term investment?
As on Jun 12,2026, the Fundamentals of QUEST LABORATORIES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of QUEST LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is QUEST LABORATORIES UnderValued or OverValued?
As on Jun 12,2026, QUEST LABORATORIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of QUEST LABORATORIES ?
As on Jun 12,2026, the Intrinsic Value of QUEST LABORATORIES is Rs. 99.57 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -8.56
Fair Value [Median EV / Sales Model] : Rs. -12.36
Fair Value [Median Price / Sales Model] : Rs. 99.57
Estimated Median Fair Value of QUEST LABORATORIES : Rs. 99.57
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.